Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Illumina, Inc.
  6. News
  7. Summary
    ILMN   US4523271090

ILLUMINA, INC.

(ILMN)
  Report
Delayed Nasdaq  -  04:00:00 2023-06-08 pm EDT
202.72 USD   +0.19%
03:50pHouse Republicans Request Information From FTC Over Illumina-Grail Merger
MT
06/06Rocky history of Illumina's Grail deal
RE
06/06Illumina appeals FTC order to divest cancer test maker Grail
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Icahn wins one board seat at Illumina

05/25/2023 | 01:59pm EDT
Carl Icahn gives an interview on FOX Business Network's Neil Cavuto show in New York

NEW YORK (Reuters) - Activist investor Carl Icahn secured enough votes at Illumina Inc's annual meeting of shareholders on Thursday to install his nominee Andrew Teno to the company's board of directors.

The vote resulted in the ouster of Illumina board chairman John Thompson. Icahn's two other board nominees, Vincent Intrieri and Jesse Lynn, did not secure enough votes to get elected.

(Reporting by Svea Herbst-Bayliss in New York; Editing by Greg Roumeliotis)


ę Reuters 2023
Stocks mentioned in the article
ChangeLast1st jan.
ICAHN ENTERPRISES L.P. 2.70% 27.77 Delayed Quote.-46.61%
ILLUMINA, INC. 0.19% 202.72 Delayed Quote.0.06%
MICROSOFT CORPORATION 0.58% 325.26 Delayed Quote.34.84%
OUSTER, INC. -6.19% 6.06 Delayed Quote.-25.14%
All news about ILLUMINA, INC.
03:50pHouse Republicans Request Information From FTC Over Illumina-Grail Merger
MT
06/06Rocky history of Illumina's Grail deal
RE
06/06Illumina appeals FTC order to divest cancer test maker Grail
RE
06/05Illumina's Board of Directors elects two experienced Independent Directors to Board
AQ
06/05Illumina releases 2022 Corporate Social Responsibility Report
PR
06/02Grail says about 400 patients incorrectly informed they may have cancer
RE
06/02More Than 400 Grail Patients Incorrectly Told They May Have Cancer - FT citing internal..
RE
06/02Illumina expands board after fight with Icahn
RE
06/02Illumina Appoints Hologic CEO Stephen MacMillan, Edwards Lifesciences CFO Scott Ullem t..
MT
06/02Illumina's Board of Directors elects two experienced Independent Directors to Board
PR
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Financials (USD)
Sales 2023 4 931 M - -
Net income 2023 45,1 M - -
Net Debt 2023 289 M - -
P/E ratio 2023 399x
Yield 2023 -
Capitalization 31 979 M 31 979 M -
EV / Sales 2023 6,54x
EV / Sales 2024 5,38x
Nbr of Employees 11 530
Free-Float 79,1%
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 202,33 $
Average target price 244,34 $
Spread / Average Target 20,8%
EPS Revisions
Managers and Directors
Francis A. deSouza Chief Executive Officer & Director
Joydeep Goswami CFO, Chief Strategy & Development Officer
Phillip G. Febbo Chief Medical Officer
Alex Aravanis CTO, Head-Research & Product Development
Carissa Rollins Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
ILLUMINA, INC.0.06%31 979
THERMO FISHER SCIENTIFIC-5.43%200 876
DANAHER CORPORATION-10.51%175 266
INTUITIVE SURGICAL, INC.15.79%107 656
BOSTON SCIENTIFIC CORPORATION9.57%72 891
SIEMENS HEALTHINEERS AG12.60%63 058
Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
fermer